Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Pharma - Others
  4. /TTK Healthcare Ltd
MomentumDeep Value

TTK Healthcare Ltd: Is It a Deep Value Opportunity?

AverageAccelerating

As of Jun 5, 2026, TTK Healthcare Ltd (Pharma - Others) has a deep value score of 46/100 (rated Average). Earnings are accelerating. 1Y return vs Nifty 500: -23%.

TTK Healthcare Ltd Key Facts

PE Ratio
18.1x
Market Cap
₹1,249 Cr
Value Score
46/100
PAT Growth YoY
+38%
Revenue Growth YoY
+15%
OPM
5.0%
PE: Cycle BottomFalling Knife

What's Happening

🔻Earnings declining and PE falling — fundamentals deteriorating

Key Numbers

PAT Growth YoY
+38%
Inflection Up
Revenue YoY
+15%
Stable
Operating Margin
5.0%
-100 bps YoY
PE Ratio
18.1
PEG Ratio
1.60
Current Price
₹899
Dividend Yield
1.11%
3Y PAT CAGR
-50%
Market Cap
1.3K Cr
Valuation
N/A

How Fast Is TTK Healthcare Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+15%+6%Stable
PAT (Net Profit)+38%-50%Inflection Up
OPM5.0%-100 bpsContracting

Other Deep Value Stocks in Pharma - Others

Syncom Formulations (India) Ltd
Average • Accelerating
53
← Back to Pharma - OthersAll Deep Value SectorsDashboard

Frequently Asked Questions: TTK Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What is TTK Healthcare Ltd's deep value score?

TTK Healthcare Ltd has a deep value score of 46/100 (rated Average). This score is calculated from three components

  • Earnings Score: 30/40 — measures PAT growth momentum across quarters
  • Underperformance Score: 14/35 — how much the stock trails Nifty 500 (deeper underperformance = higher contrarian signal)
  • Quality Score: 15/25 — operational quality (margins, revenue growth, valuation)

Is TTK Healthcare Ltd fundamentally improving?

TTK Healthcare Ltd's quarterly profit (PAT) growth trajectory

  • Latest Quarter PAT Growth (QoQ): +107%
  • Previous Quarter PAT Growth (QoQ): -48%
  • 2 Quarters Ago PAT Growth (QoQ): +57%
  • PAT Acceleration: +24.9pp (profits are accelerating)
  • 1 consecutive quarters of positive PAT growth

Why is TTK Healthcare Ltd underperforming despite good earnings?

TTK Healthcare Ltd is underperforming the market despite improving earnings — this is the core deep value thesis

  • 1-Year Return vs Nifty 500: -23%
  • 6-Month Return vs Nifty 500: -10%
  • 3-Month Return vs Nifty 500: +7%
  • Yet average quarterly PAT growth is +38% — earnings are improving
  • The market often takes time to re-rate stocks with improving fundamentals. This gap between price performance and earnings improvement is what deep value research seeks to identify.

What is the earnings momentum for TTK Healthcare Ltd?

TTK Healthcare Ltd's earnings momentum is Accelerating — profit growth is speeding up.

  • PAT QoQ progression: +57% → -48% → +107% (2Q ago → 1Q ago → latest)
  • Acceleration: +24.9pp
  • PAT YoY Growth: +38%

Is TTK Healthcare Ltd undervalued?

TTK Healthcare Ltd's valuation metrics

  • Price-to-Earnings (PE): 19.7x
  • Price-to-Book (PB): 1.2x
  • PEG Ratio: 1.6x

What are the revenue and margin trends for TTK Healthcare Ltd?

TTK Healthcare Ltd's revenue and margin trends

  • Latest Quarter Revenue Growth (QoQ): +4%
  • Average Quarterly Revenue Growth: -1%
  • Revenue Acceleration: +7.1pp
  • Latest OPM Change: +1.6pp (margins expanding)
  • Average OPM Change: +1.3pp
  • Revenue YoY: +15%

What is TTK Healthcare Ltd's trailing twelve month (TTM) performance?

TTK Healthcare Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹66 Cr
  • TTM PAT Growth: -19.5% YoY
  • TTM Revenue: ₹857 Cr
  • TTM Revenue Growth: +7.0% YoY
  • TTM Operating Margin: 3.0%

What sector does TTK Healthcare Ltd belong to?

TTK Healthcare Ltd key facts

  • Sector: Pharma - Others
  • Market Cap: ₹1.3K Cr
  • Rank in Pharma - Others: #1 by value score
  • Overall rank among all deep value stocks: #49

Is TTK Healthcare Ltd a good deep value opportunity to study?

TTK Healthcare Ltd shows limited deep value signals currently — score is 46/100 (Average). Monitor for improvement.

  • Value Score: 46/100 (Average)
  • Earnings: Accelerating
  • 1Y Underperformance: -23% vs Nifty 500

What is the bull and bear case for TTK Healthcare Ltd?

Research Signals (Bull Case)

  • Earnings accelerating — profit growth speeding up
  • Revenue growth also accelerating
  • Operating margins expanding

Risk Factors (Bear Case)

  • Margin pressure warning

Which other Pharma - Others stocks are deep value opportunities?

Other deep value stocks in Pharma - Others

  • Syncom Formulations (India) Ltd — Score 53/100, Average, earnings accelerating

How does the Pharma - Others sector look for deep value?

Pharma - Others deep value sector overview

  • 2 deep value stocks in this sector
  • Average value score: 50/100
  • Avg PAT acceleration: +19.4pp
  • Top pick: TTK Healthcare Ltd

What is deep value investing?

Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.

How is the deep value score calculated?

The deep value score (0-100) combines three factors:

- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)

Higher score indicates a stronger contrarian research signal.

The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.